BIOMARIN PHARMACEUTICAL INC (BMRN) › Total LiabilitiesBIOMARIN PHARMACEUTICAL INC (BMRN) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2009: $594.98M2010: $545.37M2011: $532.66M2012: $552.58M2013: $903.02M2014: $947.49M2015: $1.33B2016: $1.26B2017: $1.82B2018: $1.46B2019: $1.57B2020: $1.74B2021: $1.74B2022: $1.77B2023: $1.89B2024: $1.33B2025: $1.51B$1.51B2009Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$1.51B+13.2%2024$1.33B-29.6%2023$1.89B+6.7%2022$1.77B+1.9%2021$1.74B-0.2%2020$1.74B+11.1%2019$1.57B+7.4%2018$1.46B-20.0%2017$1.82B+45.1%2016$1.26B-5.4%2015$1.33B+40.2%2014$947.49M+4.9%2013$903.02M+63.4%2012$552.58M+3.7%2011$532.66M-2.3%2010$545.37M-8.3%2009$594.98M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share